Feature Adaptin Bio is leveraging immune cell hitchhiking to target brain tumors Adaptin Bio (OTCQB: APTN) is advancing a novel strategy to overcome one of the most persistent challenges in neuro-oncology—delivering effective therapies across the blood-brain barrier. By leveraging the natural... July 14, 2026